Savara
SVRA
#5877
Rank
C$1.71 B
Marketcap
C$8.37
Share price
-2.16%
Change (1 day)
176.98%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.17 Billion23.94%
2024 -C$0.14 Billion75.29%
2023 -C$77.64 Million43.38%
2022 -C$54.16 Million-11.31%
2021 -C$61.06 Million-13.3%
2020 -C$70.43 Million-36.53%
2019 -C$0.12 Billion13.76%
2018 -C$97.54 Million105.54%
2017 -C$47.46 Million34.11%
2016 -C$35.39 Million-37.43%
2015 -C$56.56 Million38.81%
2014 -C$40.74 Million33.62%
2013 -C$30.49 Million38.49%
2012 -C$22.02 Million24.59%
2011 -C$17.68 Million-36.5%
2010 -C$27.83 Million-3.14%
2009 -C$28.74 Million-23.28%
2008 -C$37.45 Million8.52%
2007 -C$34.51 Million-34.14%
2006 -C$52.4 Million184.43%
2005 -C$18.43 Million90.75%
2004 -C$9.66 Million190.35%
2003 -C$3.33 Million11.64%
2002 -C$2.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 34.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.78 Million-84.72%๐Ÿ‡บ๐Ÿ‡ธ USA